Innovative Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 22-12-2024
- Paid Up Capital ₹ 1.00 Cr
as on 22-12-2024
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.50 M
as on 22-12-2024
- Revenue 69.25%
(FY 2022)
- Profit 78.21%
(FY 2022)
- Ebitda 25.08%
(FY 2022)
- Net Worth 175.48%
(FY 2022)
- Total Assets 28.07%
(FY 2022)
About Innovative Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹3.50 M.
Mahesh Kingrani and Rajesh Chandrabhan serve as directors at the Company.
- CIN/LLPIN
U24230MH2020PTC341837
- Company No.
341837
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jul 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Innovative Pharmaceuticals Private Limited offer?
Innovative Pharmaceuticals Private Limited offers a wide range of products and services, including Sugar, Sugar Sachets, Pharmaceutical Capsules, Softgel Capsules, Vitamin Tablets & Capsules, Ayurvedic Joint Pain Relief Medicine, Ayurvedic Joint Pain Relief Capsule Tablet, Antidepressant & Anti Anxiety Medicines, Amitriptyline Tablet, Body Cream.
Who are the key members and board of directors at Innovative Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Chandrabhan  | Director | 13-Jul-2020 | Current |
| Mahesh Kingrani | Director | 13-Jul-2020 | Current |
Financial Performance of Innovative Pharmaceuticals.
Innovative Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 69.25% increase. The company also saw a substantial improvement in profitability, with a 78.21% increase in profit. The company's net worth Soared by an impressive increase of 175.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Innovative Pharmaceuticals?
In 2022, Innovative Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ikon Remedies Private LimitedActive 22 years 2 monthsMahesh Kingrani and Rajesh Chandrabhan are mutual person
Oak Sterling Vista LlpActive 1 year 7 monthsMahesh Kingrani and Rajesh Chandrabhan are mutual person
- Searle Remedies LimitedActive 12 years 6 months
Mahesh Kingrani and Rajesh Chandrabhan are mutual person
- Hathway Wellness Private LimitedActive 4 years 8 months
Mahesh Kingrani and Rajesh Chandrabhan are mutual person
- Iosis Remedies Private LimitedActive 4 years 6 months
Mahesh Kingrani and Rajesh Chandrabhan are mutual person
- Pure Organic Products Private LimitedActive 1 year 1 month
Mahesh Kingrani and Rajesh Chandrabhan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 05 Nov 2024 | ₹3.50 M | Open |
How Many Employees Work at Innovative Pharmaceuticals?
Innovative Pharmaceuticals has a workforce of 71 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Innovative Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innovative Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
